Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cutaneous squamous cell carcinoma in an autosomal-recessive Adams-Oliver syndrome patient with a novel frameshift pathogenic variant in the EOGT gene. | Am J Med Genet A | 2022 | 36059114 | PubTator, text mining | PubMed |
| Tumor microenvironment involvement in colorectal cancer progression via Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of chemoresistance. | World J Gastroenterol | 2022 | 36051330 | PubTator, text mining | PubMed |
| Exploring new pathways in endocrine-resistant breast cancer. | Explor Target Antitumor Ther | 2022 | 36045911 | PubTator, text mining | PubMed |
| Organoids capture tissue-specific innate lymphoid cell development in mice and humans. | Cell Rep | 2022 | 36044863 | PubTator, text mining | PubMed |
| JAG1-NOTCH4 mechanosensing drives atherosclerosis. | Sci Adv | 2022 | 36044575 | PubTator, text mining | PubMed |
| The lipid rafts in cancer stem cell: a target to eradicate cancer. | Stem Cell Res Ther | 2022 | 36042526 | PubTator, text mining | PubMed |
| Aberrant expression of miR-133a in endothelial cells inhibits angiogenesis by reducing pro-angiogenic but increasing anti-angiogenic gene expression. | Sci Rep | 2022 | 36042288 | PubTator, text mining | PubMed |
| Notch signaling mutations increase intra-tumor chemokine expression and predict response to immunotherapy in colorectal cancer. | BMC Cancer | 2022 | 36038820 | PubTator, text mining | PubMed |
| Stem cell-derived exosomal transcriptomes for wound healing. | Front Surg | 2022 | 36034367 | PubTator, text mining | PubMed |
| Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers. | iScience | 2022 | 36034226 | PubTator, text mining | PubMed |
| Left ventricular noncompaction: a disorder with genotypic and phenotypic heterogeneity-a narrative review. | Cardiovasc Diagn Ther | 2022 | 36033229 | PubTator, text mining | PubMed |
| Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. | Front Immunol | 2022 | 36032081 | PubTator, text mining | PubMed |
| Characterization of the Notch pathway in nasal polyps of patients with chronic rhinosinusitis: A pilot study. | Physiol Rep | 2022 | 36029197 | PubTator, text mining | PubMed |
| Herbal Ingredients in the Prevention of Breast Cancer: Comprehensive Review of Potential Molecular Targets and Role of Natural Products. | Oxid Med Cell Longev | 2022 | 36017236 | PubTator, text mining | PubMed |
| Full-Length Dystrophin Restoration via Targeted Exon Addition in DMD-Patient Specific iPSCs and Cardiomyocytes. | Int J Mol Sci | 2022 | 36012442 | PubTator, text mining | PubMed |
| Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. | Cells | 2022 | 36010607 | PubTator, text mining | PubMed |
| Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases. | Biomolecules | 2022 | 36009052 | PubTator, text mining | PubMed |
| Inborn errors of immunity associated with defects of thymic development. | Pediatr Allergy Immunol | 2022 | 36003043 | PubTator, text mining | PubMed |
| DLL4 and VCAM1 enhance the emergence of T cell-competent hematopoietic progenitors from human pluripotent stem cells. | Sci Adv | 2022 | 36001668 | PubTator, text mining | PubMed |
| Mechanisms and prospects of circular RNAs and their interacting signaling pathways in colorectal cancer. | Front Oncol | 2022 | 35992800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=44